Go Pro
LON:GENF

Genflow Biosciences (GENF) Share Price, News & Analysis

Genflow Biosciences logo
GBX 2.04 +0.37 (+21.94%)
As of 11:35 AM Eastern

About Genflow Biosciences Stock (LON:GENF)

Advanced

Key Stats

Today's Range
1.65
2.04
50-Day Range
1.63
2.25
52-Week Range
0.55
3.12
Volume
17.69 million shs
Average Volume
2.27 million shs
Market Capitalization
£11.55 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Genflow Biosciences plc is a UK based biotech company with R&D facilities in Belgium and a US office in Cambridge, MA, driven by one mission: to deliver therapeutics that potentially halt or slow the ageing process in humans and dogs. The company’s lead compound works through the delivery of a centenarian variant of the SIRT6 gene and has yielded promising preclinical results.

Receive GENF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Genflow Biosciences and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

GENF Stock News Headlines

Genflow Biosciences (LON:GENF) Shares Up 3.4% - Time to Buy?
SIRT6 gene therapy shows promise in aged dogs - ICYMI
Trump's New Dollar
Porter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. dollar reset - and most Americans don't know it's happening. The last time America underwent a monetary shift like this, under Nixon in the 1970s, it minted an average of 1,300 new millionaires a day for over half a century. Stansberry has released a new documentary naming the assets he believes are positioned to surge as a result.tc pixel
Genflow Biosciences PLC Announces Notice of AGM
See More Headlines

GENF Stock Analysis - Frequently Asked Questions

Genflow Biosciences' stock was trading at GBX 1.85 on January 1st, 2026. Since then, GENF stock has increased by 10.6% and is now trading at GBX 2.04.

Genflow Biosciences plc (LON:GENF) released its quarterly earnings results on Thursday, April, 30th. The company reported ($0.33) EPS for the quarter. Genflow Biosciences had a negative net margin of 170.64% and a positive trailing twelve-month return on equity of 332.06%.

Shares of GENF stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that Genflow Biosciences investors own include Aehr Test Systems (AEHR), Advanced Micro Devices (AMD), ARM (ARM), NIO (NIO), NVIDIA (NVDA) and PayPal (PYPL).

Company Calendar

Last Earnings
4/30/2026
Today
8/03/2026

Industry, Sector and Symbol

Stock Exchange
LON
Industry
Biotechnology
Sub-Industry
Biotechnology
Current Symbol
LON:GENF
CIK
N/A
Fax
N/A
Employees
5
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
GBX (0.33)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-£1.76 million
Net Margins
-170.64%
Pretax Margin
N/A
Return on Equity
332.06%
Return on Assets
-58.66%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.45
Quick Ratio
20.20

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
GBX 0.68 per share
Price / Cash Flow
3.00
Book Value
GBX 0.25 per share
Price / Book
8.22

Miscellaneous

Outstanding Shares
566,410,000
Free Float
N/A
Market Cap
£11.55 million
Optionable
Not Optionable
Beta
2.30
7 Stocks to Buy And Hold Forever Cover

Click the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

This page (LON:GENF) was last updated on 8/3/2026 by MarketBeat.com Staff.
From Our Partners